Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis
Titel:
Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis
Auteur:
De Roock, Wendy Claes, Bart Bernasconi, David De Schutter, Jef Biesmans, Bart Fountzilas, George Kalogeras, Konstantine T Kotoula, Vassiliki Papamichael, Demetris Laurent-Puig, Pierre Penault-Llorca, Frédérique Rougier, Philippe Vincenzi, Bruno Santini, Daniele Tonini, Giuseppe Cappuzzo, Federico Frattini, Milo Molinari, Francesca Saletti, Piercarlo De Dosso, Sara Martini, Miriam Bardelli, Alberto Siena, Salvatore Sartore-Bianchi, Andrea Tabernero, Josep Macarulla, Teresa Di Fiore, Frédéric Gangloff, Alice Oden Ciardiello, Fortunato Pfeiffer, Per Qvortrup, Camilla Hansen, Tine Plato Van Cutsem, Eric Piessevaux, Hubert Lambrechts, Diether Delorenzi, Mauro Tejpar, Sabine